Position in LLY
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$2,119,392
+$527,271 QoQ
Shares Held
1,767
+2.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.24%
of 13F equity value
Holder Rank
#2,443
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Nadler Financial Group, Inc. holds $7,548,194 across 7 Drug Manufacturers - General names. LLY ranks #1 (28.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
1,767 | $2,119,392 | |
| 2 | ABBV |
AbbVie Inc.
|
7,729 | $1,944,925 | |
| 3 | JNJ |
Johnson & Johnson
|
6,146 | $1,560,899 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,005 | $771,642 | |
| 5 | AMGN |
Amgen Inc
|
1,389 | $502,984 | |
| 6 | PFE |
Pfizer Inc
|
15,802 | $380,512 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,120 | $267,840 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,119,392 | 1,767 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $1,592,121 | 1,731 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $2,586,755 | 2,407 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $1,931,916 | 2,532 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $1,876,328 | 2,407 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $2,074,685 | 2,512 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $2,116,052 | 2,741 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $2,242,314 | 2,531 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $2,284,273 | 2,523 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $1,911,447 | 2,457 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $1,414,746 | 2,427 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $1,268,701 | 2,362 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $1,037,383 | 2,212 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $691,991 | 2,015 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $599,977 | 1,640 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $507,659 | 1,570 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $509,041 | 1,570 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $450,746 | 1,574 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $433,665 | 1,570 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $362,748 | 1,570 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $360,346 | 1,570 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $293,307 | 1,570 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $265,078 | 1,570 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $222,030 | 1,500 | Shares | Sole | 2020-10-07 | |
| 2020-06-30 | $246,270 | 1,500 | Shares | Sole | 2020-07-09 | |
| 2020-03-31 | $208,080 | 1,500 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||